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Summary and Implications 
 Administrating lipopolysaccharide (LPS) decreases 
circulating calcium (Ca) and markedly reduces both feed 
intake and milk yield in lactating cows. Calcium is involved 
in immune system activation and live yeast can increase 
feed intake.  Whether supplemental live yeast and Ca 
benefits immune-challenged cows remains unclear. 
Therefore, study objectives were to evaluate if providing an 
oral supplement containing soluble Ca, live yeast and other 
micronutrients would ameliorate LPS-induced 
hypocalcemia and production parameters in lactating dairy 
cows. 
 Providing an oral supplement containing Ca and live 
yeast prior to and following LPS administration markedly 
ameliorated the LPS-induced hypocalcemia and improved 
DMI and milk yield. Overall, utilizing an oral supplement 
may be a valuable management strategy to improve animal 
welfare and productivity during and following 
immunoactivation. Additionally, infusing i.v. LPS appears 
to be an effective technique to model hypocalcemia and to 
evaluate dietary strategies aimed at increasing circulating 
calcium in lactating dairy cows. 
Introduction 
 Hypocalcemia is a common metabolic disorder 
affecting transition dairy cows. High demand for calcium 
during the onset of lactation causes reduced circulating Ca.  
Severe hypocalcemia causes “milk fever” and requires 
immediate attention.  Subclinical hypocalcemia is not an 
overt health disorder, but it has been associated with 
decreased productivity and other economically important 
phenotypes later in lactation.    
 Previous research showed that inflammation plays a 
key role in hypocalcemia, as Ca is involved in immune 
system activation. Immuno-activation / inflammation can be 
experimentally induced by infusing LPS, a cell wall 
component of gram-negative bacteria which elicits a well-
characterized and robust immune response. Our group has 
previously shown that administrating LPS decreases 
circulating Ca and markedly reduces feed intake and milk 
yield. 
 Live yeast supplementation is thought to positively 
affect rumen pH, DMI, milk yield, and fermentation 
patterns. We hypothesized that supplementing both Ca and 
live yeast would benefit immune-challenged dairy cows. 
Therefore, study objectives were to evaluate if providing an 
oral supplement containing soluble Ca, live yeast and other 
micronutrients would ameliorate LPS-induced 
hypocalcemia and production parameters in lactating dairy 
cows.     
Materials and Methods 
 Animals and Experimental Design: All procedures 
were approved by the Iowa State University Institutional 
Animal Care and Use Committee. Twelve non-pregnant 
lactating Holstein cows (269 ± 20 DIM; 760 ± 13 kg BW; 
2.7 ± 0.3 parity) were utilized and housed in individual box-
stalls (4.57 by 4.57 m) at the Iowa State University Dairy 
Farm. Cows were allowed to acclimate for 4 d during which 
jugular catheters were implanted. The trial consisted of 2 
experimental periods (P). During P1 (3 d), cows were fed ad 
libitum and baseline data was collected. At the beginning of 
P2 (96 h) all cows were challenged i.v. with 0.375 µg/kg 
BW LPS (E. coli O55:B5; Sigma Aldrich, St. Louis, MO). 
Cows were assigned randomly to 1 of 2 treatments: 1) 
control (CON; no boluses; n = 6) or 2) a bolus containing 
Ca and live yeast, administered 0.5 pre- and 6.5 h post-LPS 
infusion (CLY; YMCP Vitall 44.718 g of elemental Ca; 
Techmix, LLC., Stewart, MN; n = 6). To isolate the effects 
of the oral supplement, cows were fasted for the first 12 h of 
P2. A stock solution of lipopolysaccride (Escherichia coli 
O55:B5; Sigma Aldrich, St. Louis, MO) was made at a 
concentration of 100 μg/mL, passed through a 0.2 μm sterile 
syringe filter (Thermo Scientific; Waltham, MA), and 
stored in a sterile glass bottle 24 h prior to P2. The total 
volume of LPS solution administrated was approximately 3 
mL. Cows were individually fed a TMR once daily (0800 h) 
and orts were measured before the a.m. feeding. The TMR 
was formulated to meet or exceed the predicted 
requirements (NRC, 2001) of energy, protein, minerals, and 
vitamins. Cows were milked twice daily (0600 and 1800 h) 
during P1 and P2. Milk yield was recorded and a sample for 
composition analysis was obtained at each milking. Samples 
were stored at 4˚C with a preservative (bronopol tablet; 
DandF Control System, San Ramon, CA) until analysis by 
Dairy Lab Services (Dubuque, IA) using AOAC approved 
infrared analysis equipment and procedures. 
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 Rectal temperature (Tr), and respiration rate (RR) were 
obtained -1, -0.5, 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 6.5, 7, 8, 9, 10, 
11, 12, 24, 48, 72, and 96 h relative to LPS infusion. Rectal 
temperatures were measured using a standard digital 
thermometer (GLA M700 Digital Thermometer, San Luis 
Obispo, CA). Respiration rates were determined by counting 
flank movements during 15 sec intervals and multiplying by 
four to obtain breaths per minute (bpm).  
 Blood samples were collected -1, -0.5, 0, 0.5, 1, 1.5, 2, 
3, 4, 5, 6, 6.5, 7, 8, 9, 10, 11, 12, 24, 48, 72, and 96 h 
relative to LPS infusion. Circulating glucose and ionized Ca 
(iCa) concentrations were measured using an iStat handheld 
machine and cartridge (CG8+; Abbott Point of Care, 
Princeton, NJ). 
     Calculations and Statistical analysis: Area under the 
curve (AUC) for iCa was calculated through 96 h post-LPS 
by linear trapezoidal summation between successive pairs of 
iCa levels and time coordinates after subtracting baseline 
values. 
 Each animal’s respective response variable was 
analyzed using repeated measures with an autoregressive 
covariance structure for DMI, milk yield, and milk 
composition and spatial power law structure for vitals and 
iSTAT parameters (glucose and iCa levels). The repeated 
effect was either day/time relative to LPS infusion. Each 
specific variable’s pre-infusion value served as a covariate. 
Effects of treatments, time/day, treatment by time/day 
interaction were analyzed using PROC MIXED (SAS Inst. 
Inc., Cary, NC). Results are reported as LSmeans and were 
considered different when P ≤ 0.05 and tend to differ if P < 
0.10. 
Results and Discussion 
 Body temperature indices:  During P2, LPS 
administration caused mild hyperthermia (+0.21°C) relative 
to baseline (P < 0.01; Figure 1A). Likewise, respiration rate 
was increased 31 bpm between 0.5 to 1 h post LPS infusion 
(P < 0.01; Figure 1B) compared to baseline values; 
however, no treatment differences were observed in Tr and 
RR (P > 0.05; Figure 1).   
 Circulating iCa and glucose concentrations: 
Following LPS administration, circulating iCa decreased in 
both treatments but supplemental CLY ameliorated the 
hypocalcemia (469% by 48 h AUC: -10.8 vs. -1.9 
mmol/L·h; P < 0.01; Figure 2A). LPS administration had 
increased (55%) circulating glucose from 0 to 2 h post LPS 
infusion (P < 0.01; Figure 2B) compared with baseline. 
Circulating glucose in both CON and CLY cows decreased 
similarly between 3 and 12 h post LPS-infusion (17%; P = 
0.40; Figure 2B) compared to baseline. 
 Dry matter intake: Overall, LPS markedly decreased 
DMI (60%; P < 0.01) similarly for both treatments on d 1, 
but overall (d1-4) DMI tended to be reduced less (14 vs 
30%; P = 0.06) in CLY supplemented vs CON cows (Figure 
3A). 
 Milk yield and milk composition: LPS reduced (P 
<0.01) milk yield on d 1 and 2 (48 and 61%, respectively). 
Overall (d 1-4), CLY supplemented cows tended (P = 0.11) 
to produce more milk (32%) following the LPS challenge 
and this effect was most pronounced on d 4 (20.7 vs 28.0 
kg/d; P <0.04; Figure 3B). Milk urea nitrogen (MUN) was 
decreased (11%) in CLY cows compared to CON cows (P = 
0.01; Figure 4). 
 
Overall Summary and Conclusion 
 In conclusion, providing an oral supplement containing 
Ca and live yeast prior to and following LPS administration 
markedly ameliorated the LPS-induced hypocalcemia and 
improved DMI and milk yield. Overall, utilizing an oral 
supplement may be a valuable management strategy to 
improve animal welfare and productivity during transition 
period and immunoactivation / inflammation (i.e. hospital 
pen implications). Furthermore, infusing i.v. LPS appears to 
be an effective technique to model hypocalcemia and to 
evaluate dietary strategies aimed at increasing circulating 
calcium in transitioning lactating dairy cows.    
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Figure 1. Effects of an oral supplement on body temperature indices in lactating dairy cows. A) Temperature (Tr), and B) 
Respiration rate (RR.). CON = control; CLY = calcium + live yeast bolus. 
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Figure 2. Effects of an oral supplement on A) circulating Ca and B) glucose in lactating dairy cows.                                
                          CON = control; CLY = calcium + live yeast bolus. 
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Figure 3. Effects of an oral supplement on A) DMI and B) Milk yield. The mean value from d 1 to 3 of P1 is represented by 
P1 on the x-axis. CON = control; CLY = calcium + live yeast bolus. 
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Figure 4: Effects of an oral supplement on MUN in lactating dairy cows.  
                        CON = control; CLY = calcium + live yeast bolus. 
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